Tristel (TSTL) Competitors

GBX 455
+10.00 (+2.25%)
(As of 04/23/2024 ET)

TSTL vs. BVC, AMS, BVXP, OXB, APH, HVO, AVCT, NIOX, BXP, and 4BB

Should you be buying Tristel stock or one of its competitors? The main competitors of Tristel include BATM Advanced Communications (BVC), Advanced Medical Solutions Group (AMS), Bioventix (BVXP), Oxford Biomedica (OXB), Alliance Pharma (APH), hVIVO (HVO), Avacta Group (AVCT), NIOX Group (NIOX), Beximco Pharmaceuticals (BXP), and 4basebio (4BB). These companies are all part of the "medical" sector.

Tristel vs.

BATM Advanced Communications (LON:BVC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, community ranking, analyst recommendations, dividends, earnings, media sentiment and risk.

41.8% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 50.3% of Tristel shares are owned by institutional investors. 26.2% of BATM Advanced Communications shares are owned by company insiders. Comparatively, 5.4% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Tristel had 2 more articles in the media than BATM Advanced Communications. MarketBeat recorded 3 mentions for Tristel and 1 mentions for BATM Advanced Communications. Tristel's average media sentiment score of 0.58 beat BATM Advanced Communications' score of 0.34 indicating that BATM Advanced Communications is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BATM Advanced Communications
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tristel
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BATM Advanced Communications pays an annual dividend of GBX 1 per share and has a dividend yield of 5.1%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 2.9%. Tristel pays out 10,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Tristel has lower revenue, but higher earnings than BATM Advanced Communications.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£122.83M0.69£2.51MN/AN/A
Tristel£39.49M5.47£6.04M£0.133,500.00

BATM Advanced Communications has a beta of 0.57, meaning that its stock price is 43% less volatile than the S&P 500. Comparatively, Tristel has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500.

Tristel has a consensus price target of GBX 390, indicating a potential downside of 14.29%. Given BATM Advanced Communications' higher possible upside, analysts plainly believe Tristel is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Tristel
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Tristel has a net margin of 15.29% compared to Tristel's net margin of -0.16%. BATM Advanced Communications' return on equity of 20.35% beat Tristel's return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-0.16% -0.17% 0.59%
Tristel 15.29%20.35%9.89%

BATM Advanced Communications received 42 more outperform votes than Tristel when rated by MarketBeat users. However, 57.36% of users gave Tristel an outperform vote while only 49.48% of users gave BATM Advanced Communications an outperform vote.

CompanyUnderperformOutperform
BATM Advanced CommunicationsOutperform Votes
190
49.48%
Underperform Votes
194
50.52%
TristelOutperform Votes
148
57.36%
Underperform Votes
110
42.64%

Summary

Tristel beats BATM Advanced Communications on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TSTL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TSTL vs. The Competition

MetricTristelMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£216.08M£5.90B£4.81B£1.42B
Dividend Yield2.73%1.86%5.47%11.82%
P/E Ratio3,500.00321.24202.701,760.04
Price / Sales5.47168.432,567.91333,958.80
Price / Cash20.96100.1331.7533.13
Price / Book6.893.224.662.55
Net Income£6.04M£176.93M£101.81M£183.08M
7 Day Performance-3.19%-2.09%-0.12%1.25%
1 Month Performance1.68%-5.35%-5.56%9.14%
1 Year Performance36.84%-2.18%9.97%14.54%

Tristel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
0 of 5 stars
GBX 18.05
-5.2%
N/A-26.2%£78.73M£122.83M2,800.00980Gap Down
AMS
Advanced Medical Solutions Group
2.2254 of 5 stars
GBX 182
-0.8%
GBX 300
+64.8%
-22.6%£395.56M£126.21M2,600.00800Gap Down
BVXP
Bioventix
0 of 5 stars
GBX 4,600
+2.2%
N/A+19.6%£240.12M£13.60M2,822.0912Gap Up
OXB
Oxford Biomedica
0.8333 of 5 stars
GBX 197
+0.9%
GBX 498.75
+153.2%
-52.8%£196.92M£119.02M-307.81891
APH
Alliance Pharma
2.9614 of 5 stars
GBX 36.10
-0.6%
GBX 80.75
+123.7%
-42.0%£195.08M£170.05M-3,610.00285
HVO
hVIVO
0 of 5 stars
GBX 27.68
+1.8%
N/A+49.7%£188.33M£60.48M-1.00N/APositive News
AVCT
Avacta Group
0 of 5 stars
GBX 50.71
-0.1%
N/A-66.3%£177.74M£16.02M-316.93120
NIOX
NIOX Group
0.5638 of 5 stars
GBX 64.62
-1.2%
GBX 77
+19.2%
+45.7%£273.16M£36.80M3,230.8092
BXP
Beximco Pharmaceuticals
0 of 5 stars
GBX 36.50
flat
N/A-14.1%£162.83M£41.65B456.255,700
4BB
4basebio
0 of 5 stars
GBX 1,070
+1.9%
N/A+59.5%£137.07M£311,000.00-2,098.0478

Related Companies and Tools

This page (LON:TSTL) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners